Both in Biotechnology
Century Therapeutics vs Scribe Therapeutics
Over the past year IPSC returned −22.7% and SCTX returned −48.0%; their daily moves had a correlation of 0.29.
IPSC −22.7% SCTX −48.0%Growth of $1, one year, split-adjusted
| Metric | IPSC | SCTX |
|---|---|---|
| Price | $1.50 | $15.47 |
| Market cap | $271.6M | $292.9M |
| Today | +2.04% | +0.32% |
| 1 month | −2.0% | −7.9% |
| 6 months | −34.5% | — |
| Year to date | +50.8% | — |
| 1 year | +153.4% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $119.7M | — |
| Dividend yield | — | — |
| Volatility (60d) | 72.7% | — |
| Short % of float | 23.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).